US 12281140
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 12281140 (Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P13/12, A61P3/00